within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AC24_Ticagrelor;
model Ticagrelor 
   extends Pharmacolibrary.Drugs.ATC.B.B01AC24;

  annotation(Documentation(
    info ="<html><body><p>Ticagrelor is a direct-acting, oral, reversible P2Y12 receptor antagonist used as an antiplatelet agent for the prevention of atherothrombotic events in patients with acute coronary syndrome or a history of myocardial infarction. Approved for clinical use in many countries including the US and EU.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after single and multiple oral doses.</p><h4>References</h4><ol><li><p>Gelbenegger, G, &amp; Jilma, B (2022). Clinical pharmacology of antiplatelet drugs. <i>Expert review of clinical pharmacology</i> 15(10) 1177–1197. DOI:<a href=&quot;https://doi.org/10.1080/17512433.2022.2121702&quot;>10.1080/17512433.2022.2121702</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36065676/&quot;>https://pubmed.ncbi.nlm.nih.gov/36065676</a></p></li><li><p>Wang, ZT, et al., &amp; Cai, WM (2020). Effect of tea polyphenols on the oral and intravenous pharmacokinetics of ticagrelor in rats and its in vitro metabolism. <i>Journal of food science</i> 85(4) 1285–1291. DOI:<a href=&quot;https://doi.org/10.1111/1750-3841.15096&quot;>10.1111/1750-3841.15096</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32157685/&quot;>https://pubmed.ncbi.nlm.nih.gov/32157685</a></p></li><li><p>Ma, T, et al., &amp; Li, J (2022). SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor. <i>Frontiers in pharmacology</i> 13 1027627–None. DOI:<a href=&quot;https://doi.org/10.3389/fphar.2022.1027627&quot;>10.3389/fphar.2022.1027627</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36339534/&quot;>https://pubmed.ncbi.nlm.nih.gov/36339534</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Ticagrelor;
